Open Label, Safety and Efficacy Study of Topical Investigational Drug to Treat Patients With Psoriasis - Contacts and Locations

Home Search Study Topics Glossary

Open Label, Safety and Efficacy Study of Topical Investigational Drug to Treat Patients With Psoriasis

This study is currently recruiting participants.

Study NCT00617994. Last updated on January 8, 2009.

Information provided by Incyte Corporation

Please refer to this study by its ClinicalTrials.gov identifier: NCT00617994

Contacts

Contact: Robert Flores

302-498-6949

Locations

United States, Minnesota
	Recruiting
Fridley, Minnesota, United States, 55432
United States, New York
	Recruiting
Rochester, New York, United States, 14623
United States, Texas
	Recruiting
Austin, Texas, United States, 78759
	Recruiting
College Station, Texas, United States, 77840

Sponsors and Collaborators

Incyte Corporation

Investigators

Study Director:

William Williams, MD

Incyte Corporation